United States Healthcare Equipment & Supplies

Orchestra Biomed Holdings Inc (OBIO)

Track

Over the past 90 days, Orchestra Biomed Holdings Inc. saw 10 insider transactions, resulting in a net positive value of approximately $157,948. While officer Darren Sherman engaged in planned sales, other insiders, including David P. Hochman and Jason Aryeh, executed buy transactions. This activity follows the company's May 2026 earnings report, which showed a 25.5% EPS beat.
Ticker: OBIO Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Orchestra Biomed Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sherman Darren
See Remarks
2 sales — total 128,850 USD
Planned sale 1 Jul 2026
Value US$4,962,769.77 | Price 315.44 | Shares 26,653
Proposed sale 1 Jul 2026
Value US$2,879,684.02 | Price 32.94 | Shares 45,256
Buy 1 Jun 2026
Value US$1,214,716.84 | Price 297.15 | Shares 94,474
Planned sale 1 Jun 2026
Value US$58,050.00 | Price 3.87 | Shares 15,000
Proposed sale 1 Jun 2026
Value US$58,049.53 | Price 3.87 | Shares 15,000
Buy 18 May 2026
Value US$2,493.75 | Price 3.75 | Shares 665
Buy 15 May 2026
Value US$34,986.90 | Price 3.90 | Shares 8,971
Buy 15 May 2026
Value US$18,850.00 | Price 3.77 | Shares 5,000
Buy 14 May 2026
Value US$82,600.00 | Price 4.13 | Shares 20,000
Sale 27 Apr 2026
Value US$132.16 | Price 4.13 | Shares 32
Buy 13 Mar 2026
Value US$42,900.00 | Price 4.29 | Shares 10,000
Buy 14 Nov 2025
Value US$20,350.00 | Price 4.07 | Shares 5,000
Buy 19 Sep 2025
Value US$2,450.00 | Price 2.45 | Shares 1,000
Buy 25 Aug 2025
Value US$15,033.60 | Price 2.61 | Shares 5,760
Buy 25 Aug 2025
Value US$5,100.00 | Price 2.55 | Shares 2,000
Buy 25 Aug 2025
Value US$7,860.00 | Price 2.62 | Shares 3,000
Buy 21 Aug 2025
Value US$14,940.00 | Price 2.49 | Shares 6,000
Buy 4 Aug 2025
Value US$55,000.00 | Price 2.75 | Shares 20,000
Buy 1 Aug 2025
Value US$1,925,000.00 | Price 2.75 | Shares 700,000
Sale 26 Jun 2025
Value US$8,183.15 | Price 3.05 | Shares 2,683
Proposed sale 26 Jun 2025
Value US$8,194.15 | Price 3.05 | Shares 2,683
Buy 30 Apr 2025
Value US$149,201.00 | Price 2.99 | Shares 49,900
Buy 29 Apr 2025
Value US$126,500.00 | Price 2.53 | Shares 50,000
Buy 23 Dec 2024
Value US$18,640.00 | Price 4.66 | Shares 4,000
Buy 19 Dec 2024
Value US$4,830.00 | Price 4.83 | Shares 1,000
Buy 18 Dec 2024
Value US$24,550.00 | Price 4.91 | Shares 5,000
Buy 25 Sep 2024
Value US$9,460.00 | Price 4.73 | Shares 2,000
Buy 25 Sep 2024
Value US$9,400.00 | Price 4.70 | Shares 2,000
Buy 25 Sep 2024
Value US$9,480.00 | Price 4.74 | Shares 2,000
Buy 25 Sep 2024
Value US$7,290.00 | Price 4.86 | Shares 1,500
Buy 24 Sep 2024
Value US$12,275.00 | Price 4.91 | Shares 2,500
Proposed sale 10 Sep 2024
Value US$9,620.29 | Price 5.34 | Shares 1,800
Sale 10 Sep 2024
Value US$9,612.00 | Price 5.34 | Shares 1,800
Proposed sale 10 Sep 2024
Value US$36,647.12 | Price 5.31 | Shares 6,904
Sale 10 Sep 2024
Value US$36,660.24 | Price 5.31 | Shares 6,904
Sale 9 Sep 2024
Value US$37,285.92 | Price 5.48 | Shares 6,804
Proposed sale 9 Sep 2024
Value US$37,319.26 | Price 5.48 | Shares 6,804
Sale 9 Sep 2024
Value US$9,774.00 | Price 5.43 | Shares 1,800
Proposed sale 9 Sep 2024
Value US$9,773.66 | Price 5.43 | Shares 1,800
Sale 6 Sep 2024
Value US$11,280.00 | Price 5.64 | Shares 2,000
Proposed sale 6 Sep 2024
Value US$11,279.11 | Price 5.64 | Shares 2,000
Proposed sale 6 Sep 2024
Value US$38,513.03 | Price 5.65 | Shares 6,819
Sale 6 Sep 2024
Value US$38,527.35 | Price 5.65 | Shares 6,819
Sale 5 Sep 2024
Value US$40,721.85 | Price 5.85 | Shares 6,961
Proposed sale 5 Sep 2024
Value US$40,708.62 | Price 5.85 | Shares 6,961
Sale 4 Sep 2024
Value US$41,705.70 | Price 6.10 | Shares 6,837
Proposed sale 4 Sep 2024
Value US$41,702.28 | Price 6.10 | Shares 6,837
Buy 14 Aug 2024
Value US$14,600.00 | Price 5.84 | Shares 2,500
Buy 25 Jun 2024
Value US$6,950.00 | Price 6.95 | Shares 1,000
Buy 30 May 2024
Value US$28,000.00 | Price 7.00 | Shares 4,000
Buy 30 Jan 2023
Value US$63,435.64 | Price 9.28 | Shares 6,835
Buy 24 Jan 2023
Value US$18,085,120.00 | Price 10.00 | Shares 1,808,512
Buy 22 Jul 2022
Value US$10,010,000.00 | Price 10.01 | Shares 1,000,000
Buy 6 Aug 2020
Value US$4,500,000.00 | Price 10.00 | Shares 450,000
Buy 4 Aug 2020
Value US$200,000.00 | Price 10.00 | Shares 20,000
Buy 4 Aug 2020
Value US$100,000.00 | Price 10.00 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-07-01 PlS Planned sale
3.1
Sherman Darren

See Remarks

Executive Director
26,653 -35.2%
315.44
US$4,962,770 		26,653 -35.2% 315.44 US$4,962,770
2026-07-01 2026-07-01 PrS Proposed sale
3.1
Sherman Darren

Officer; Director

Executive Director
45,256
32.94
US$2,879,684 		45,256 32.94 US$2,879,684
2026-06-02 2026-06-01 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
94,474 -39.0%
297.15
US$1,214,717 		94,474 -39.0% 297.15 US$1,214,717
2026-06-02 2026-06-01 PlS Planned sale
3.1
Sherman Darren

See Remarks

Executive Director
15,000 -1.3%
3.87
US$58,050 		15,000 -1.3% 3.87 US$58,050
2026-06-01 2026-06-01 PrS Proposed sale
3.1
Sherman Darren

Officer; Director

Executive Director
15,000
3.87
US$58,050 		15,000 3.87 US$58,050
2026-05-20 2026-05-18 B Purchase
2.4
Aryeh Jason
Non-Executive Director
665 +0.6%
3.75
US$2,494 		665 +0.6% 3.75 US$2,494
2026-05-19 2026-05-15 B Purchase
2.4
Aryeh Jason
Non-Executive Director
8,971 +8.3%
3.90
US$34,987 		8,971 +8.3% 3.90 US$34,987
2026-05-19 2026-05-15 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
5,000 +0.5%
3.77
US$18,850 		5,000 +0.5% 3.77 US$18,850
2026-05-18 2026-05-14 B Purchase
2.9
Fain Eric S
Non-Executive Director
20,000 +27.9%
4.13
US$82,600 		20,000 +27.9% 4.13 US$82,600
2026-04-29 2026-04-27 S Sale
2.7
RTW INVESTMENTS, LP
Large shareholder
32 -0.0%
4.13
US$132 		32 -0.0% 4.13 US$132
2026-03-16 2026-03-13 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
10,000 +0.9%
4.29
US$42,900 		10,000 +0.9% 4.29 US$42,900
2025-11-17 2025-11-14 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
5,000 +0.8%
4.07
US$20,350 		5,000 +0.8% 4.07 US$20,350
2025-09-19 2025-09-19 B Purchase
2.4
Aryeh Jason
Non-Executive Director
1,000 +0.9%
2.45
US$2,450 		1,000 +0.9% 2.45 US$2,450
2025-08-25 2025-08-25 B Purchase
2.9
Fain Eric S
Non-Executive Director
5,760 +8.7%
2.61
US$15,034 		5,760 +8.7% 2.61 US$15,034
2025-08-25 2025-08-25 B Purchase
2.8
Taylor Andrew Lawrence

Chief Financial Officer

Officer
2,000 +0.4%
2.55
US$5,100 		2,000 +0.4% 2.55 US$5,100
2025-08-25 2025-08-25 B Purchase
3.1
Sherman Darren

See Remarks

Executive Director
3,000 +0.3%
2.62
US$7,860 		3,000 +0.3% 2.62 US$7,860
2025-08-25 2025-08-21 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
6,000 +0.9%
2.49
US$14,940 		6,000 +0.9% 2.49 US$14,940
2025-08-04 2025-08-04 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
20,000 +6.1%
2.75
US$55,000 		20,000 +6.1% 2.75 US$55,000
2025-08-05 2025-08-01 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
700,000 +15.2%
2.75
US$1,925,000 		700,000 +15.2% 2.75 US$1,925,000
2025-06-27 2025-06-26 S Sale
2.9
Fain Eric S
Non-Executive Director
2,683 -5.0%
3.05
US$8,183 		2,683 -5.0% 3.05 US$8,183
2025-06-26 2025-06-26 PrS Proposed sale
2.9
Fain Eric S

Director

Non-Executive Director
2,683
3.05
US$8,194 		2,683 3.05 US$8,194
2025-05-01 2025-04-30 B Purchase
2.7
RTW INVESTMENTS, LP
Large shareholder
49,900 +0.6%
2.99
US$149,201 		49,900 +0.6% 2.99 US$149,201
2025-04-29 2025-04-29 B Purchase
2.7
RTW INVESTMENTS, LP
Large shareholder
50,000 +0.6%
2.53
US$126,500 		50,000 +0.6% 2.53 US$126,500
2024-12-26 2024-12-23 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
4,000 +0.7%
4.66
US$18,640 		4,000 +0.7% 4.66 US$18,640
2024-12-20 2024-12-19 B Purchase
2.8
Taylor Andrew Lawrence

Chief Financial Officer

Officer
1,000 +0.3%
4.83
US$4,830 		1,000 +0.3% 4.83 US$4,830
2024-12-19 2024-12-18 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
5,000 +0.9%
4.91
US$24,550 		5,000 +0.9% 4.91 US$24,550
2024-09-26 2024-09-25 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
2,000 +inf%
4.73
US$9,460 		2,000 +inf% 4.73 US$9,460
2024-09-26 2024-09-25 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
2,000 +inf%
4.70
US$9,400 		2,000 +inf% 4.70 US$9,400
2024-09-26 2024-09-25 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
2,000 +inf%
4.74
US$9,480 		2,000 +inf% 4.74 US$9,480
2024-09-26 2024-09-25 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
1,500 +0.4%
4.86
US$7,290 		1,500 +0.4% 4.86 US$7,290
2024-09-26 2024-09-24 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
2,500 +0.4%
4.91
US$12,275 		2,500 +0.4% 4.91 US$12,275
2024-09-10 2024-09-10 PrS Proposed sale
2.9
Fain Eric S

Director

Non-Executive Director
1,800
5.34
US$9,620 		1,800 5.34 US$9,620
2024-09-10 2024-09-10 PrS Proposed sale
3.1
Sherman Darren

Officer; Director

Executive Director
6,904
5.31
US$36,647 		6,904 5.31 US$36,647
2024-09-10 2024-09-10 S Sale
3.1
Sherman Darren

See Remarks

Executive Director
6,904 -0.9%
5.31
US$36,660 		6,904 -0.9% 5.31 US$36,660
2024-09-10 2024-09-10 S Sale
2.9
Fain Eric S
Non-Executive Director
1,800 -4.2%
5.34
US$9,612 		1,800 -4.2% 5.34 US$9,612
2024-09-10 2024-09-09 S Sale
3.1
Sherman Darren

See Remarks

Executive Director
6,804 -0.9%
5.48
US$37,286 		6,804 -0.9% 5.48 US$37,286
2024-09-10 2024-09-09 S Sale
2.9
Fain Eric S
Non-Executive Director
1,800 -4.0%
5.43
US$9,774 		1,800 -4.0% 5.43 US$9,774
2024-09-09 2024-09-09 PrS Proposed sale
2.9
Fain Eric S

Director

Non-Executive Director
1,800
5.43
US$9,774 		1,800 5.43 US$9,774
2024-09-09 2024-09-09 PrS Proposed sale
3.1
Sherman Darren

Officer; Director

Executive Director
6,804
5.48
US$37,319 		6,804 5.48 US$37,319
2024-09-10 2024-09-06 S Sale
2.9
Fain Eric S
Non-Executive Director
2,000 -4.3%
5.64
US$11,280 		2,000 -4.3% 5.64 US$11,280
2024-09-06 2024-09-06 PrS Proposed sale
3.1
Sherman Darren

Officer; Director

Executive Director
6,819
5.65
US$38,513 		6,819 5.65 US$38,513
2024-09-06 2024-09-06 PrS Proposed sale
2.9
Fain Eric S

Director

Non-Executive Director
2,000
5.64
US$11,279 		2,000 5.64 US$11,279
2024-09-06 2024-09-06 S Sale
3.1
Sherman Darren

See Remarks

Executive Director
6,819 -0.9%
5.65
US$38,527 		6,819 -0.9% 5.65 US$38,527
2024-09-06 2024-09-05 S Sale
3.1
Sherman Darren

See Remarks

Executive Director
6,961 -0.9%
5.85
US$40,722 		6,961 -0.9% 5.85 US$40,722
2024-09-05 2024-09-05 PrS Proposed sale
3.1
Sherman Darren

Officer; Director

Executive Director
6,961
5.85
US$40,709 		6,961 5.85 US$40,709
2024-09-06 2024-09-04 S Sale
3.1
Sherman Darren

See Remarks

Executive Director
6,837 -0.9%
6.10
US$41,706 		6,837 -0.9% 6.10 US$41,706
2024-09-04 2024-09-04 PrS Proposed sale
3.1
Sherman Darren

Officer; Director

Executive Director
6,837
6.10
US$41,702 		6,837 6.10 US$41,702
2024-08-15 2024-08-14 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
2,500 +0.4%
5.84
US$14,600 		2,500 +0.4% 5.84 US$14,600
2024-06-26 2024-06-25 B Purchase
3.6
Hochman David P

See Remarks

Executive Director
1,000 +0.3%
6.95
US$6,950 		1,000 +0.3% 6.95 US$6,950
2024-06-03 2024-05-30 B Purchase
1.4
Little William Reed

See Remarks

Officer
4,000 +1.3%
7.00
US$28,000 		4,000 +1.3% 7.00 US$28,000
2023-02-01 2023-01-30 B Purchase
3.2
Medtronic plc
Large shareholder
6,835 +0.1%
9.28
US$63,436 		6,835 +0.1% 9.28 US$63,436
2023-01-26 2023-01-24 B Purchase
3.4
WONG RODERICK

Chief Executive Officer

Executive Director Large shareholder
1,808,512 +180.9%
10.00
US$18,085,120 		1,808,512 +180.9% 10.00 US$18,085,120
2022-07-25 2022-07-22 B Purchase
3.4
WONG RODERICK

Chief Executive Officer

Executive Director
1,000,000 +inf%
10.01
US$10,010,000 		1,000,000 +inf% 10.01 US$10,010,000
2020-08-06 2020-08-06 B Purchase
HSAC 2 Holdings, LLC
Large shareholder
450,000 +11.5%
10.00
US$4,500,000 		450,000 +11.5% 10.00 US$4,500,000
2020-08-06 2020-08-04 B Purchase
Sirota Stephanie A

VP of Corp Stratege and Comm

Officer
20,000 +inf%
10.00
US$200,000 		20,000 +inf% 10.00 US$200,000
2020-08-06 2020-08-04 B Purchase
Lee Alice

VP Operations, Sec & Treasurer

Officer
10,000 +inf%
10.00
US$100,000 		10,000 +inf% 10.00 US$100,000
Explore more

More insider trading research around Orchestra Biomed Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America